HERITAGE AND LEGACY

The Founder of Med-Chem Labs and the Discover of Monolaurin, Professor Jon J. Kabara, PhD. Dr. Kabara’s pioneering research in the discovery of monolaurin in mother’s milk in the 1960’s is the basis for bringing Lauricidin® to the healthcare community.

Professor Jon J. Kabara, PhD, Discoverer of Monolaurin

Over 40 years of Commitment to Healthy Patients and Communities

Dr. Kabara’s pioneering research in the discovery of monolaurin in mother’s milk in the 1960’s is the basis for bringing Lauricidin® to the healthcare community. We now work with a wide spectrum of healthcare professionals (MD, DC, DO, ND, LMT, CCN, CNS, LAc, LN, CN, RN, DDS, DMD, etc…) across the world.

Discovery of Monolaurin

At the University of Detroit Department of Chemistry, Dr. Kabara and his undergraduate students began experimenting with the nutritional effects of fatty acids, particularly the 12-carbon chain fatty acid lauric acid, and its monoglyceride – known as Monolaurin.

In Dr. Kabara’s own words: “Our studies eventually indicated that certain fatty acids and especially their monoglycerides (a fatty acid attached to glycerol) found in mother’s milk had extraordinary properties.”

With the findings of Dr. Kabara and his students, Med-Chem Laboratories, Inc. was born.

Now over 40 years later, Lauricidin® is recommended worldwide by thousands of physicians, health professionals, retail consumers and researchers alike for its immune-promoting properties*.

With the growing recognition of the health benefits of coconut oil, more and more people are recognizing the unique properties of its 95%+ pure monolaurin extract, Lauricidin®.

Commercially, Lauricidin® is manufactured by joining one part lauric acid to one part glycerol to create pure monolaurin. Our lauric acid is derived from pure coconut oil.

Dr. Kabara’s Professional Experience

Dr. Kabara’s professional experience began in 1948 as a research assistant at the University of Illinois- Department of Biochemistry. Just eight years after graduation from the University of Chicago, he received his full professorship at the University of Detroit (1965). In 1969, as Professor and Associate Dean, he helped establish a new College of Osteopathic Medicine which became the first affiliated school of Osteopathic Medicine at a major university (Michigan State University).

Achievements

A well-recognized lecturer, author, and philanthropist, Dr. Kabara also received a number of accolades throughout his career.

American Men of Science
20th Century Award for Achievement
Who’s Who in Technology Today (Fourth Edition)
Who’s Who in Science
International Who’s Who in Community Service
Outstanding Educators of America
Who’s Who in America (Fifty-Fourth Edition)
Two Thousand Men of Achievement

Dr. Kabara was granted over 15 scholarships, has had more than 30-research sponsors and has been awarded over 16 U.S. and foreign patents. He is credited with more than 200 publications including book chapters or books.

Education

St. Mary’s University, Winona, Minnesota (1945-1948)
Degree: B.S. (Major Chemistry, Minor Mathematics and Philosophy)

University of Miami, Miami, Florida (1948-1950)
Degree: M.S. (Major-Organic Chemistry)

University of Chicago, Chicago, Illinois (1953-1959)
Degree: Ph.D (Major –Phamacology, Minor-Biochemistry)

Giving Back

The Kabara family continues to support new research discoveries and the development of young leaders.

About Med-Chem Labs

Med-Chem Labs, Inc. was established in 1966 by Dr. Jon Kabara PhD and are the proud makers of Lauricidin® a nutritional supplement (derived from coconut oil) for better health and self-healing.*

Dr. Kabara’s pioneering research in the discovery of Monolaurin in the 1960s is the basis for bringing Lauricidin® to the healthcare community.

Read Dr. Kabara's Story

Med-Chem News

Jon J Kabara - Honored Alumni at Saint Mary's University

After graduating from Saint Mary’s, Jon Kabara earned an M.S. in Organic Chemistry at the University of Miami, and

Kabara's Donate $1.5 million to enhance science, business at Saint Mary's

WINONA, Minn. — With a recent $1.5 million donation, Betty Kabara, CEO of Med-Chem Labs based in Goodyear, AZ—curre

Epi-Shield®

topical lauricidin

EPI-SHIELD®, a skin balm, has a unique three part topical system that contains an emollient to help moisturize skin, a vegetable-based plasticizer to promote skin conditioning, and contains LAURICIDIN®.

Contact Us

Med-Chem Labs, Inc.
15655 W Roosevelt Street
Suite 108
Goodyear, AZ 85338
Keep Scooping